ID

35264

Beschreibung

Study ID: 100449 Clinical Study ID: 100449 Study Title: Long-term Follow-Up studies at Years 16-20, to evaluate the persistence of immune response of GSK Biologicals’ hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers in comparison with a historical control group Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00240539 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis B Vaccine, Recombinant Trade Name: Engerix-B Study Indication: Hepatitis B

Stichworte

  1. 25.02.19 25.02.19 -
Rechteinhaber

GSK group of companies

Hochgeladen am

25. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Persistence of immune response of Hepatitis B vaccine in newborns of HBeAg+ and HBsAg+ mothers

Visit 22 - 26 (Follow-Up)

Visit 22 (Year 16) Follow-up
Beschreibung

Visit 22 (Year 16) Follow-up

Protocol
Beschreibung

Protocol

Datentyp

integer

Center
Beschreibung

Center

Datentyp

integer

Date of visit
Beschreibung

Date of visit

Datentyp

date

Subject Number
Beschreibung

Subject Number

Datentyp

integer

INFORMED CONSENT
Beschreibung

INFORMED CONSENT

I certify that Informed Consent has been obtained prior to any study procedure.
Beschreibung

I certify that Informed Consent has been obtained prior to any study procedure.

Datentyp

boolean

Informed Consent Date
Beschreibung

InformedConsentDate

Datentyp

date

DEMOGRAPHICS
Beschreibung

DEMOGRAPHICS

Date of birth:
Beschreibung

PREVIOUS STUDY: 103860/272 (EXT: HBV-115) Subject number will be the same as in the previous study.

Datentyp

date

Gender
Beschreibung

Gender

Datentyp

text

Race
Beschreibung

Race

Datentyp

text

If Other, please specify race
Beschreibung

OtherRace

Datentyp

text

Height
Beschreibung

Height

Datentyp

integer

Maßeinheiten
  • cm
cm
Weight
Beschreibung

Weight

Datentyp

float

Maßeinheiten
  • kg
kg
LABORATORY TESTS
Beschreibung

LABORATORY TESTS

Has a blood sample been taken?
Beschreibung

BLOOD SAMPLE

Datentyp

boolean

If Yes, please record the date
Beschreibung

DateBloodSampleTaken

Datentyp

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Beschreibung

PreviousHepatitisVaccination

Datentyp

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Beschreibung

PreviousHistoryOfHipatitisB

Datentyp

boolean

If Yes, please specify below
Beschreibung

Specify

Datentyp

text

Visit 23 (Year 17) Follow-up
Beschreibung

Visit 23 (Year 17) Follow-up

Date of visit
Beschreibung

VisitDate

Datentyp

date

LABORATORY TESTS
Beschreibung

LABORATORY TESTS

Has a blood sample been taken?
Beschreibung

BLOOD SAMPLE

Datentyp

boolean

Please specify the date of blood sample taken
Beschreibung

DateBloodSampleTaken

Datentyp

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Beschreibung

PreviousHepatitisBVaccination

Datentyp

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Beschreibung

PreviousHistoryOfHepatitisB

Datentyp

boolean

If Yes, please specify
Beschreibung

Specify

Datentyp

text

Visit 24 (Year 18) Follow-up
Beschreibung

Visit 24 (Year 18) Follow-up

Date of visit
Beschreibung

Visit Date

Datentyp

date

LABORATORY TESTS
Beschreibung

LABORATORY TESTS

Has a blood sample been taken?
Beschreibung

BLOOD SAMPLE

Datentyp

boolean

Please specify the date of blood sample taken
Beschreibung

DateBloodSampleTaken

Datentyp

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Beschreibung

PreviousHepatitisBVaccination

Datentyp

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Beschreibung

PreviousHistoryOfHepatitisB

Datentyp

boolean

If Yes, please specify
Beschreibung

Specify

Datentyp

text

Visit 25 (Year 19) Follow-up
Beschreibung

Visit 25 (Year 19) Follow-up

Date of visit
Beschreibung

VisitDate

Datentyp

date

LABORATORY TESTS
Beschreibung

LABORATORY TESTS

Has a blood sample been taken?
Beschreibung

BLOOD SAMPLE

Datentyp

boolean

Please specify the date of blood sample taken
Beschreibung

DateBloodSampleTaken

Datentyp

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Beschreibung

PreviousHepatitisBVaccination

Datentyp

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Beschreibung

PreviousHistoryOfHepatitisB

Datentyp

boolean

If Yes, please specify
Beschreibung

Specify

Datentyp

text

Visit 26 (Year 20) Follow-up
Beschreibung

Visit 26 (Year 20) Follow-up

Date of visit
Beschreibung

VisitDate

Datentyp

date

LABORATORY TESTS
Beschreibung

LABORATORY TESTS

Has a blood sample been taken?
Beschreibung

BLOOD SAMPLE

Datentyp

boolean

Please specify the date of blood sample taken
Beschreibung

DateBloodSampleTaken

Datentyp

date

Did the subject receive a dose of Hepatitis B vaccine since the last visit
Beschreibung

PreviousHepatitisBVaccination

Datentyp

boolean

Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
Beschreibung

PreviousHistoryOfHepatitisB

Datentyp

boolean

If Yes, please specify
Beschreibung

Specify

Datentyp

text

FOLLOW-UP STUDIES
Beschreibung

FOLLOW-UP STUDIES

Would the subject be willing to participate in a follow-up study?
Beschreibung

FollowUpStudiesParticipation

Datentyp

boolean

If No, please specify
Beschreibung

If No, please specify

Datentyp

text

If AE or SAE, please specify
Beschreibung

AE/SAE

Datentyp

text

If Other, please specify
Beschreibung

OtherSpecify

Datentyp

text

INVESTIGATOR'S SIGNATURE
Beschreibung

INVESTIGATOR'S SIGNATURE

I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
Beschreibung

Investigator'sConfirmationDate

Datentyp

date

Investigator's signature
Beschreibung

Investigator's signature

Datentyp

text

Printed Investigator's name
Beschreibung

Printed Investigator's name

Datentyp

text

Reason for non participation
Beschreibung

Reason for non participation

Protocol number
Beschreibung

Protocol number

Datentyp

integer

Center
Beschreibung

Center

Datentyp

integer

Previous study
Beschreibung

e.g., 103860 / 272 (EXT:HBV-115)

Datentyp

text

Tracking Document
Beschreibung

Tracking Document

Previous Subject Number
Beschreibung

Previous Subject Number

Datentyp

integer

Date of Birth
Beschreibung

BirthDate

Datentyp

date

Please document reason for non participation
Beschreibung

Please document reason for non participation

Datentyp

text

In case of death, please specify date
Beschreibung

DeathDate

Datentyp

date

Date of Contact
Beschreibung

Date of Contact

Datentyp

date

Investigator's Signature
Beschreibung

Investigator's Signature

Investigator name
Beschreibung

please PRINT name

Datentyp

text

Signature:
Beschreibung

Signature:

Datentyp

text

Date:
Beschreibung

Date:

Datentyp

date

Ähnliche Modelle

Visit 22 - 26 (Follow-Up)

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Visit 22 (Year 16) Follow-up
Protocol
Item
Protocol
integer
Center
Item
Center
integer
Date of visit
Item
Date of visit
date
Subject Number
Item
Subject Number
integer
Item Group
INFORMED CONSENT
I certify that Informed Consent has been obtained prior to any study procedure.
Item
I certify that Informed Consent has been obtained prior to any study procedure.
boolean
InformedConsentDate
Item
Informed Consent Date
date
Item Group
DEMOGRAPHICS
Date of birth:
Item
Date of birth:
date
Item
Gender
text
Code List
Gender
CL Item
Male (1)
CL Item
Female (2)
Item
Race
text
Code List
Race
CL Item
Black (1)
CL Item
Arabic/North African (2)
CL Item
White/Caucasian (3)
CL Item
East & South East Asian (4)
CL Item
South Asian (5)
OtherRace
Item
If Other, please specify race
text
Height
Item
Height
integer
Weight
Item
Weight
float
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
If Yes, please record the date
date
PreviousHepatitisVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHipatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify below
text
Item Group
Visit 23 (Year 17) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 24 (Year 18) Follow-up
Visit Date
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 25 (Year 19) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
Visit 26 (Year 20) Follow-up
VisitDate
Item
Date of visit
date
Item Group
LABORATORY TESTS
BLOOD SAMPLE
Item
Has a blood sample been taken?
boolean
DateBloodSampleTaken
Item
Please specify the date of blood sample taken
date
PreviousHepatitisBVaccination
Item
Did the subject receive a dose of Hepatitis B vaccine since the last visit
boolean
PreviousHistoryOfHepatitisB
Item
Did the subject develop clinical signs possibly related to hepatitis B since last visit or suffered from hepatitis B?
boolean
Specify
Item
If Yes, please specify
text
Item Group
FOLLOW-UP STUDIES
FollowUpStudiesParticipation
Item
Would the subject be willing to participate in a follow-up study?
boolean
Item
If No, please specify
text
Code List
If No, please specify
CL Item
Adverse Events, or Serious Adverse Events (1)
CL Item
Other (2)
AE/SAE
Item
If AE or SAE, please specify
text
OtherSpecify
Item
If Other, please specify
text
Item Group
INVESTIGATOR'S SIGNATURE
Investigator'sConfirmationDate
Item
I confirm that I have reviewed the data in this Case Report Form for this subject. All information entered by myself or my colleagues is, to the best of my knowledge, complete and accurate, as of the date below.
date
Investigator's signature
Item
Investigator's signature
text
Printed Investigator's name
Item
Printed Investigator's name
text
Item Group
Reason for non participation
Protocol number
Item
Protocol number
integer
Center
Item
Center
integer
Previous study
Item
Previous study
text
Item Group
Tracking Document
Previous Subject Number
Item
Previous Subject Number
integer
BirthDate
Item
Date of Birth
date
Item
Please document reason for non participation
text
Code List
Please document reason for non participation
CL Item
Subject not eligible (1)
CL Item
Subject lost to follow-up or not reached (2)
CL Item
Subject eligible but not willing to participate due to adverse events, or serious adverse event (3)
CL Item
Subject eligible but not willing to participate due to other reasons (4)
CL Item
Subject died (5)
DeathDate
Item
In case of death, please specify date
date
Date of Contact
Item
Date of Contact
date
Item Group
Investigator's Signature
Investigator name
Item
Investigator name
text
Signature:
Item
Signature:
text
Date:
Item
Date:
date

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video